Literature DB >> 3427269

Effects of diltiazem and verapamil on responses to acetylcholine.

R E Wachtel1.   

Abstract

1. The calcium channel antagonists diltiazem and verapamil were found to alter the average lifetime of ion channels activated by acetylcholine (ACh). 2. Average channel lifetime was determined from the decay phase of miniature endplate currents at the neuromuscular junction of mouse hemidiaphragms and from direct recording of single channel currents activated by ACh from BC3H1 mouse tumour cells in culture. 3. Both diltiazem and verapamil reduced average channel lifetime in a dose-dependent manner. For each drug, concentrations as high as 20 microM-100 microM were required to decrease channel lifetime by 50%. 4. Single channel recording experiments also showed that both diltiazem and verapamil greatly decreased the frequency of opening events at concentrations as low as 2 microM to 5 microM. This finding is consistent with an enhancement of receptor desensitization.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3427269      PMCID: PMC1853694          DOI: 10.1111/j.1476-5381.1987.tb11357.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  The effects of verapamil on metabolism and contractility of the toad skeletal muscle.

Authors:  D J Chiarandini; P J Bentley
Journal:  J Pharmacol Exp Ther       Date:  1973-07       Impact factor: 4.030

2.  Blocking of frog endplate channels by the organic calcium antagonist D600.

Authors:  P D Bregestovski; R Miledi; I Parker
Journal:  Proc R Soc Lond B Biol Sci       Date:  1980-12-31

3.  Neuromuscular blocking action of verapamil in cats.

Authors:  B J Kraynack; N W Lawson; J Gintautas
Journal:  Can Anaesth Soc J       Date:  1983-05

4.  Functional consequences of agonist-mediated state transitions in the cholinergic receptor. Studies in cultured muscle cells.

Authors:  S Sine; P Taylor
Journal:  J Biol Chem       Date:  1979-05-10       Impact factor: 5.157

5.  Relationship between reversible antagonist occupancy and the functional capacity of the acetylcholine receptor.

Authors:  S M Sine; P Taylor
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

6.  The relationship between agonist occupation and the permeability response of the cholinergic receptor revealed by bound cobra alpha-toxin.

Authors:  S M Sine; P Taylor
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

7.  The action of verapamil on the rate of spontaneous release of transmitter at the frog neuromuscular junction.

Authors:  S J Publicover; C J Duncan
Journal:  Eur J Pharmacol       Date:  1979-02-15       Impact factor: 4.432

8.  Effect of "calcium antagonist" D-600 on the postsynaptic membrane.

Authors:  P D Bregestovski; V I Iljin
Journal:  J Physiol (Paris)       Date:  1980-09

9.  Purine effects at the neuromuscular junction and their modification by theophylline, imidazole and verapamil.

Authors:  J A Ribeiro; M L Dominguez; M J Gonçalves
Journal:  Arch Int Pharmacodyn Ther       Date:  1979-04

10.  Multiple controls for the synthesis of muscle-specific proteins in BC3H1 cells.

Authors:  R Munson; K L Caldwell; L Glaser
Journal:  J Cell Biol       Date:  1982-02       Impact factor: 10.539

View more
  6 in total

1.  Inhibition of neurally-evoked transmitter release by calcium channel antagonists in rat parasympathetic ganglia.

Authors:  G R Seabrook; D J Adams
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

2.  Pre- and postsynaptic effects of the calcium channel blocker verapamil at neuromuscular junctions.

Authors:  E R Sharifullina; R A Afzalov; M V Talantova; F Vyskochil; R A Giniatullin
Journal:  Neurosci Behav Physiol       Date:  2002 May-Jun

3.  Differential effects of calcium channel antagonists (omega-conotoxin GVIA, nifedipine, verapamil) on the electrically-evoked release of [3H]acetylcholine from the myenteric plexus, phrenic nerve and neocortex of rats.

Authors:  I Wessler; D J Dooley; J Werhand; F Schlemmer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

4.  Lambert-Eaton myasthenic syndrome without anti-calcium channel antibody: adverse effect of calcium antagonist diltiazem.

Authors:  S Ueno; Y Hara
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

5.  Differential potentiation by calcium antagonists of neuromuscular blockade induced by pancuronium and succinylcholine in cats in vivo.

Authors:  M Ocaña; E Del Pozo; R Carlos; J M Baeyens
Journal:  J Neural Transm Gen Sect       Date:  1992

6.  "Calcium bombs" as harbingers of synaptic pathology and their mitigation by magnesium at murine neuromuscular junctions.

Authors:  Kosala N Dissanayake; Robert R Redman; Harry Mackenzie; Michael Eddleston; Richard R Ribchester
Journal:  Front Mol Neurosci       Date:  2022-07-26       Impact factor: 6.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.